zejulahcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: */overlays/ Disallow: */404/ Disallow: */thank-you/ Disallow: */search/ Disallow: /dosing/quadra-dosing/ Disallow: /efficacy/quadra-study/ Disallow: /safety/quadra-safety/ Disallow: /efficacy/nova-study/ Disallow: /dosing/nova-dosing/ Disallow: /safety/nova-safety/ Sitemap: | ||
Meta Tags
| Title | Ovarian Cancer Treatment | ZEJULA (niraparib) for |
| Description | If she Learn about ZEJULA (niraparib), a once-daily oral PARP inhibitor for adults with ovarian cancer. Find more info about this maintenance |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 34.107.225.66 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
zejulahcp.com Valuation
|
US$8,006,687
Last updated: 2023-05-07 07:53:56
zejulahcp.com has Semrush global rank of 1,321,933. zejulahcp.com has an estimated worth of US$ 8,006,687, based on its estimated Ads revenue. zejulahcp.com receives approximately 923,849 unique visitors each day. Its web server is located in United States, with IP address 34.107.225.66. According to SiteAdvisor, zejulahcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$8,006,687 |
| Daily Ads Revenue | US$7,391 |
| Monthly Ads Revenue | US$221,724 |
| Yearly Ads Revenue | US$2,660,684 |
| Daily Unique Visitors | 61,590 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| zejulahcp.com. | A | 899 | IP: 34.107.225.66 |
| zejulahcp.com. | NS | 86400 | NS Record: ns-398.awsdns-49.com. |
| zejulahcp.com. | NS | 86400 | NS Record: ns-904.awsdns-49.net. |
| zejulahcp.com. | NS | 86400 | NS Record: ns-1327.awsdns-37.org. |
| zejulahcp.com. | NS | 86400 | NS Record: ns-2044.awsdns-63.co.uk. |
| zejulahcp.com. | TXT | 300 | TXT Record: facebook-domain-verification=epmlpbzpl4mfptym3oicmoygi16ngj |
| zejulahcp.com. | TXT | 300 | TXT Record: google-site-verification=5oFzJB4fj-AQC3Blxn33bqUUUewRR41CWYycU6Mrr-w |
HtmlToTextCheckTime:2023-05-07 07:53:56
| You are about to leave a GSK website. By clicking this link, you will be taken to a website that is independent from GSK. The site you are linking to is not controlled or endorsed by GSK, and GSK is not responsible for the content provided on that site. Yes No You are using an unsupported browser. Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge. Timeout Important Prescribing Information Dec 2022 Important Prescribing Information Sept 2022 For US HCPs For US Healthcare Professionals Prescribing Info Prescribing Information Patient Information GSK MedInfo Request Samples Prescribing Information Prescribing Information Patient Information Visit US Patient Site GSKMedInfo Request Samples Menu Search Go Search About Ovarian Cancer About ZEJULA Efficacy Efficacy Overview PRIMA: First-Line Maintenance Treatment of Advanced Ovarian Cancer Safety Safety Overview PRIMA Safety Dosing and AR Management |
HTTP Headers
HTTP/1.1 301 Moved Permanently Cache-Control: private Content-Type: text/html; charset=UTF-8 Referrer-Policy: no-referrer Location: https://zejulahcp.com/ Content-Length: 219 Date: Wed, 27 Oct 2021 15:41:23 GMT HTTP/2 301 date: Wed, 27 Oct 2021 15:41:23 GMT server: Apache location: https://www.zejulahcp.com/ content-type: text/html; charset=iso-8859-1 via: 1.1 google set-cookie: GCLB=CMe1idj9l47AtQE; path=/; HttpOnly; expires=Thu, 28-Oct-2021 15:41:23 GMT alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43" HTTP/2 200 date: Wed, 27 Oct 2021 15:41:23 GMT server: Apache strict-transport-security: max-age=63072000; accept-ranges: bytes vary: Accept-Encoding x-platform: cf65-prd-aem-publish-2 x-frame-options: SAMEORIGIN cache-control: public, max-age=0, s-maxage=86400 content-type: text/html; charset=UTF-8 via: 1.1 google set-cookie: GCLB=CNjC4Yr8grvB7QE; path=/; HttpOnly; expires=Thu, 28-Oct-2021 15:41:23 GMT alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43" |
zejulahcp.com Whois Information
Domain Name: ZEJULAHCP.COM Registry Domain ID: 2199349872_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2020-09-02T11:16:06Z Creation Date: 2017-12-12T21:56:00Z Registry Expiry Date: 2023-12-12T21:56:00Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1327.AWSDNS-37.ORG Name Server: NS-2044.AWSDNS-63.CO.UK Name Server: NS-398.AWSDNS-49.COM Name Server: NS-904.AWSDNS-49.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T12:02:44Z <<< |